MedPath

合肥英太制药有限公司

Ownership
-
Established
2010-11-02
Employees
-
Market Cap
-
Website
www.hfytzy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

19

NMPA:19

Drug Approvals

Fluvoxamine Maleate Tablets

Product Name
马来酸氟伏沙明片
Approval Number
国药准字H20254151
Approval Date
May 13, 2025
NMPA

Fluvoxamine Maleate Tablets

Product Name
马来酸氟伏沙明片
Approval Number
国药准字H20254152
Approval Date
May 13, 2025
NMPA

Oxcarbazepine Tablets

Product Name
奥卡西平片
Approval Number
国药准字H20249153
Approval Date
Oct 22, 2024
NMPA

Oxcarbazepine Tablets

Product Name
奥卡西平片
Approval Number
国药准字H20249154
Approval Date
Oct 22, 2024
NMPA

Rasagiline Mesylate Tablets

Product Name
甲磺酸雷沙吉兰片
Approval Number
国药准字H20244908
Approval Date
Sep 19, 2024
NMPA

Apixaban Tablets

Product Name
阿哌沙班片
Approval Number
国药准字H20233857
Approval Date
Jun 30, 2023
NMPA

Cinacalcet Hydrochloride Tablets

Product Name
盐酸西那卡塞片
Approval Number
国药准字H20233817
Approval Date
Jun 27, 2023
NMPA

Desloratadine Tablets

Product Name
地氯雷他定片
Approval Number
国药准字H20223357
Approval Date
May 31, 2022
NMPA

Lacosamide Tablets

Product Name
拉考沙胺片
Approval Number
国药准字H20223089
Approval Date
Feb 23, 2022
NMPA

Lacosamide Tablets

Product Name
拉考沙胺片
Approval Number
国药准字H20223088
Approval Date
Feb 23, 2022
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.